Dose Escalation Study of PF-06741086 In Healthy Subjects
NCT02531815
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
PF-06741086
DRUG:
Placebo
Sponsor
Pfizer